David Scadden, Director of Agios Pharmaceuticals AGIO, has filed 0 purchases and 6 sales on the open market. Over the past 12 months that comes to a net sale of $25K. The latest trade was on 06/18.

DS

DS

David Scadden

Director

Company

Agios Pharmaceuticals AGIO

First filing

23/06/05

Trades

39 trades

Buys / sales

0 / 6

12-month net buying

−$25K

Last trade

06/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Agios PharmaceuticalsAGIO	Open-market sale10b5-1 plan	25/11/12	25/11/14	200 sh	$43.84	$8,768	−1.1%
Agios PharmaceuticalsAGIO	Open-market sale10b5-1 plan	25/10/08	25/10/10	200 sh	$41.00	$8,200	−1.1%
Agios PharmaceuticalsAGIO	Open-market sale10b5-1 plan	25/09/30	25/10/02	200 sh	$40.00	$8,000	−1.1%
Agios PharmaceuticalsAGIO	Open-market sale10b5-1 plan	25/08/27	25/08/29	200 sh	$40.00	$8,000	−1.1%
Agios PharmaceuticalsAGIO	Open-market sale10b5-1 plan	25/07/10	25/07/15	1,400 sh	$40.00	$56,000	−7.4%
Agios PharmaceuticalsAGIO	Open-market sale10b5-1 plan	24/12/11	24/12/13	200 sh	$46.28	$9,256	−1.3%